GGrantIndex
← Leaderboards

Marxa L. Figueiredo

University Of California Los Angeles

$5,304,752
Attributed
$5,304,752
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $769.8K · FY200622
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$5,304,752 · 6

By mechanism

R01$3,642,977 · 2
R21$787,535 · 2
K01$782,962 · 1
P20$91,278 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Others in their field

Top investigators on “Homeostasis

Research focus

HomeostasisGene Delivery SystemGrowthIn VivoBaseNeoplastic CellTumorTumor GrowthPreventSignal TransductionGene DeliveryLaboratoriesTissuesMediatingAffectBone CellPositioning AttributePainQuality Of LifeOsteoclastsBoneImmuneCytokineOsteoblasts

Grant awards (27)

Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 Sonodelivery$335,126
R01 · FY2022 · AR · contact PI
Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 Sonodelivery$328,415
R01 · FY2021 · AR · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$409,870
R01 · FY2020 · CA · contact PI
Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 Sonodelivery$338,635
R01 · FY2020 · AR · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$350,990
R01 · FY2019 · CA · contact PI
Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 Sonodelivery$338,694
R01 · FY2019 · AR · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$58,854
R01 · FY2019 · CA · contact PI
Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 Sonodelivery$362,812
R01 · FY2018 · AR · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$349,968
R01 · FY2018 · CA · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$56,995
R01 · FY2018 · CA · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$350,644
R01 · FY2017 · CA · contact PI
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery$361,974
R01 · FY2016 · CA · contact PI
Pro-peptide gene delivery for treating prostate cancer bone metastases$160,582
R21 · FY2014 · CA · contact PI
Pro-peptide gene delivery for treating prostate cancer bone metastases$198,778
R21 · FY2013 · CA · contact PI
Preventing prostate cancer progression by ASC delivery of PEDF and IFNb$186,664
R21 · FY2013 · CA · contact PI
Preventing prostate cancer progression by ASC delivery of PEDF and IFNb$62,961
R21 · FY2013 · CA · contact PI
Preventing prostate cancer progression by ASC delivery of PEDF and IFNb$178,550
R21 · FY2012 · CA · contact PI
MECHANISMS OF XMRV ONCOGENESIS IN PROSTATE CELLS$91,278
P20 · FY2011 · RR · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$99,774
K01 · FY2010 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$54,358
K01 · FY2010 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$151,216
K01 · FY2009 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$53,298
K01 · FY2009 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$46,702
K01 · FY2009 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$148,384
K01 · FY2008 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$61,583
K01 · FY2007 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$54,247
K01 · FY2007 · CA · contact PI
p12CDK2AP1 Regulation of Normal and Neoplastic Growth$113,400
K01 · FY2006 · CA · contact PI